Skip to content

BCNA urges young women outside national screening guidelines to remain vigilant about fast-growing breast cancer frequently missed or misdiagnosed

By API User

March 2, 2026 – Breast Cancer Network Australia (BCNA) is highlighting the critical need for early detection of Triple Negative Breast Cancer (TNBC) ahead of Awareness Day on Tuesday March 3, warning that this fast-growing subtype of cancer is frequently missed or misdiagnosed in younger Australian women who sit outside the national screening program. With … Continued

Women in respiratory leadership take centre stage at TSANZSRS 2026

By API User

Key Facts: The TSANZ Symposium on women in respiratory leadership, hosted by The Thoracic Society of Australia and New Zealand and exclusively sponsored by Chiesi Australia, will be held in Perth in March 2026, featuring leaders from Australia, New Zealand, and the USA.  The event will explore leadership paths, representation and barriers affecting career progression … Continued

Join us today for the Cronulla Memory Walk & Jog

By API User

  The 2026 Cronulla Memory Walk & Jog is fast approaching, with the much-anticipated event taking place this weekend on Sunday 1 March at Don Lucas Reserve.   With the big day kicking off at 7:30am, we welcome everyone in the Cronulla community to join their fellow participants as they walk, jog or run for … Continued

Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE034

By API User

IDE034 is a B7H3/PTK7 bispecific TOP1 ADC designed to target tumor cells expressing both B7H3 and PTK7 preferentially, and is being evaluated as monotherapy and in combination with IDEAYA’s PARG inhibitor IDE161. IDEAYA has dosed the first patient in its Phase 1 trial of IDE034, initially evaluating safety, tolerability, and PK. First dosing triggers a … Continued

Galderma’s Nemluvio® (nemolizumab) Demonstrates Long-Term Disease Control in Prurigo Nodularis up to Three Years

By API User

Results from an interim analysis of the OLYMPIA long-term extension (LTE) study show that Nemluvio maintained long-term disease control up to three years, with clinically meaningful improvements in itch intensity, skin lesions and quality of life1 These results, to be presented at 2026 Winter Clinical™ Miami, mark the longest LTE study in prurigo nodularis reported … Continued

Get active for your brain health and beat dementia in Bunbury!

By API User

The 2026 Bunbury Memory Walk & Jog is just weeks away, with the event taking place on Saturday, 28 March at Back Beach, Bunbury.    As Dementia Australia’s largest annual fundraising initiative, Memory Walk & Jog brings communities together to get active, get connected and support Australians living with dementia, their families and carers.   … Continued

Get active for your brain health and beat dementia in Perth!

By API User

The 2026 Perth Memory Walk & Jog is just weeks away, with the event taking place on Sunday 29 March at Burswood Park.    As Dementia Australia’s largest annual fundraising initiative, Memory Walk & Jog brings communities together to get active, get connected and support Australians living with dementia, their families and carers.   More … Continued

Future respiratory workforce in focus: TSANZSRS ASM 2026 Postgraduate Workshops

By API User

Key Facts: Full-day postgraduate and advanced trainee workshops scheduled for 27 March 2026 at Perth Convention Centre, focusing on strengthening respiratory workforce capabilities Programme includes comprehensive sessions on Interstitial Lung Disease, Bronchiectasis, and Pulmonary embolism management, featuring multidisciplinary approaches and expert-led discussions Morning workshops cover lung nodule management, occupational lung diseases, professional development, and tuberculosis … Continued

Senate Committee gives green light to registered nurse prescribing reform

By API User

The Senate Community Affairs Legislation Committee has recommended the passage of the Health Legislation Amendment (Prescribing of Pharmaceutical Benefits) Bill 2025, paving the way for designated registered nurses to prescribe medicines under the Pharmaceutical Benefits Scheme (PBS) from July 2026. The Australian College of Nursing welcomes the Committee’s unanimous recommendation to pass the bill, after … Continued

Emerging class of antibiotics to tackle global tuberculosis crisis

By API User

Researchers from the University of Sydney and the Centenary Institute have discovered how a promising class of experimental antibiotics disrupts the bacterium that causes tuberculosis (TB), paving the way for urgently needed new treatments.   Globally, TB remains a major health crisis, claiming around 1.2 million lives each year and ranking among the world’s deadliest … Continued